Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 05, 2024 08:05 ET | Source: Axial Therapeutics

Axial Therapeutics to Present at Upcoming Conferences

WOBURN, Mass., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Axial Therapeutics, a clinical-stage biotechnology company dedicated to the development of gut-targeted, small molecule therapeutics for neurological...
March 29, 2023 08:00 ET | Source: Axial Therapeutics

Axial Therapeutics Announces Key Research and Development Promotions to Advance Clinical and Preclinical Pipeline of Small Molecule Microbiome Therapeutics

– Phase 2b clinical trial for AB-2004 in autism irritability ongoing and enrollment anticipated to be complete by end of 2023 – – IND-enabling studies ongoing for Parkinson’s Disease development...
January 31, 2023 10:04 ET | Source: The Insight Partners

Industrial Fans Market Size to Hit $12.64 Billion by 2028, Globally, Driven by Major Technological Advancements – Growth Report by The Insight Partners

New York, Jan. 31, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners; “Industrial Fans Market Size, Share, Growth, Trends and Global Forecast to 2028 - COVID-19 Impact and Global Analysis...
November 01, 2022 08:00 ET | Source: Axial Therapeutics

Axial Therapeutics CEO A. Stewart Campbell to Present at Microbiome Connect: USA 2022

WOBURN, Mass., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Axial Therapeutics, a clinical-stage biopharmaceutical company dedicated to the development of gut-targeted, small molecule therapeutics for...
October 11, 2022 08:00 ET | Source: Axial Therapeutics

Axial Therapeutics Expands Clinical Development Capabilities with Key Appointments

- Clinical development operations focused on ongoing Phase 2b clinical trial of AB-2004 in autism; data anticipated in 2023 - - Team also supporting additional microbiome-based small molecule...
October 06, 2022 08:00 ET | Source: Axial Therapeutics

Axial Therapeutics to Present at BioJapan Conference

WOBURN, Mass., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Axial Therapeutics Inc., a clinical-stage biopharmaceutical company dedicated to the development of gut-targeted, small molecule therapeutics for...
August 01, 2022 06:00 ET | Source: TECAT Performance Systems

Businesses Distress During Pandemic, but TECAT Performance Systems Grows

ANN ARBOR, Mich., Aug. 01, 2022 (GLOBE NEWSWIRE) -- TECAT Performance Systems today announces a new online store to supplement the strength of its product and accessories offerings. A clear sign of...
October 19, 2021 07:00 ET | Source: TECAT Performance Systems

TECAT Announces New Patent for Integrated Wireless Data System and Method for Pump Control

ANN ARBOR, Mich., Oct. 19, 2021 (GLOBE NEWSWIRE) -- TECAT Performance Systems today announces a new patent for an integrated wireless data system and method for pumpjack control. It is the second...